Meta Pixel

News and Announcements

Focus – Trends in Capital Raising

  • Published December 20, 2022 5:20AM UTC
  • Publisher Callum Melrose
  • Categories Capital Raising Tips

There are three primary trends affecting how startups raise capital: the rise of the super angel, the emergence of new crowdfunding platforms, and the increased focus on high net worth individuals (HNWIs )…⬇️

1. The Rise of the Super Angel

The number of super angels is on the rise, with firms investing in startups at an increasing rate. These angels are typically wealthy individuals who have the time and resources to invest in early-stage companies. They are a key source of capital for startups, and their interest in investing can help drive innovation.

2. The Emergence of New Crowdfunding Platforms

Several new crowdfunding platforms are emerging, which is driving interest in investing in startups. These platforms allow individuals to invest in a wide range of companies, from technology startups to consumer products. They also offer investors more opportunities to invest in multiple companies at once, which can increase the chances of a successful investment.

3. The Increased Focus on HNWIs

HNWIs are increasingly interested in investing in startups. This is because they see the potential for high returns on their investments, and they want to support innovative companies. As a result, more startups are seeking out HNWI investors to help them reach their funding goals.

These are only three of the trends affecting how startups raise capital. As startup companies continue to seek new sources of funding, it is important to stay up-to-date on the latest trends. This way, you can make the best possible decisions when seeking capital and investing in startups.

Looking for a platform to raise capital? Click here to discover how Wholesale Investor can help you.

Your capital engagement platform

With a 14-year track record, a network of 32,000+ investors, and a capital raising platform, Wholesale investor is a leading investment platform for start-ups, scale-ups, emerging growth companies, and small caps.

Capital Insights
The Ferrari of Immunotherapy: Chimeric’s High-Stakes Race to Cure Cancer

In the high-stakes world of biotechnology, the most sophisticated weapon against cancer isn’t a new chemical compound but the patient’s own immune system, re-engineered with the precision of a high-performance engine. “This particular CAR T is like a Ferrari,” says Dr. Rebecca McQualter, CEO of Chimeric Therapeutics (ASX: CHM). “It’s got two big engines on […]

Capital Insights
From Algae Pioneers to a Natural Revolution: The Second Act of WRS Bioproducts

As the US FDA prepares to phase out synthetic food colors by the end of 2026, WRS Bioproducts is stepping in to solve a looming supply crisis. Led by industry pioneer Harry Rosen, the company is leveraging 40 years of industrial algae farming expertise to scale production of natural, superior-quality beta-carotene, positioning itself as a vital supplier in the rapidly shifting global market for natural ingredients.

Join over 45,000+ sophisticated investors

Join Now